The store will not work correctly when cookies are disabled.
6-bromo-N-(2-chlorophenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA1077741
PubChem CID: 46882745
Max Phase: Preclinical
Molecular Formula: C15H11BrClN3O
Molecular Weight: 364.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccc(Br)cn2c1C(=O)Nc1ccccc1Cl
Standard InChI: InChI=1S/C15H11BrClN3O/c1-9-14(20-8-10(16)6-7-13(20)18-9)15(21)19-12-5-3-2-4-11(12)17/h2-8H,1H3,(H,19,21)
Standard InChI Key: ZUSNVDFABMKMFR-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
5.1194 -7.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1183 -8.5065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8331 -8.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8313 -7.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5467 -7.6755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5515 -8.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3390 -8.7528 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8209 -8.0813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3312 -7.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3482 -6.5925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0701 -6.1931 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6414 -6.1671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6564 -5.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3828 -4.9462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3982 -4.1221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6930 -3.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9665 -4.0996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9547 -4.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2341 -5.3242 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.4049 -7.2668 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
8.6459 -8.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 1 2 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 2 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
9 5 1 0
1 20 1 0
8 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.63 | Molecular Weight (Monoisotopic): 362.9774 | AlogP: 4.31 | #Rotatable Bonds: 2 |
Polar Surface Area: 46.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.17 | CX LogP: 3.28 | CX LogD: 3.28 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.74 | Np Likeness Score: -2.42 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |